A new study in The American Journal of Psychiatry found lower availability of a brain receptor called metabotropic glutamate receptor 5 (mGlu5) across autistic adults’ brains. Researchers say this finding may relate to an imbalance between excitatory signals (which make neurons fire) and inhibitory signals (which act like a brake).
The team used MRI and PET scans to compare 16 autistic adults and 16 neurotypical adults; PET gives molecular information while MRI shows brain anatomy. Fifteen autistic participants also had EEG tests, and lower mGlu5 levels were linked to EEG measures. Researchers note limits: PET is costly and uses radiation, and the study only looked at autistic adults. Scientists plan future studies in children and adolescents.
Difficult words
- receptor — small protein on cells that receives signals
- excitatory — causing neurons to send signals more often
- inhibitory — reducing neuron activity or slowing signals
- imbalance — lack of equal or correct amounts
- neurotypical — person without autism or a related diagnosis
- scan — medical image of the body's insidescans
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever had or known someone who had a brain scan (MRI, PET or EEG)? How was the experience?
- Why is it important to study children and adolescents after findings in adults?
- What concerns might people have about PET scans and why?
Related articles
Rwanda strengthens response to Rift Valley Fever outbreak
Rwanda reported a second Rift Valley Fever outbreak near the Tanzania border and has increased surveillance and livestock vaccination. Officials say lack of rapid diagnostic tests slows detection, while a human vaccine candidate enters Phase II trials.
Study: Year‑round RSV Immunization Could Reduce Big Outbreaks
A study in Science Advances finds that offering RSV immunizations year‑round would lower the chance of large seasonal outbreaks in the United States. Researchers compared spread in cities and rural areas and tested seasonal versus year‑round schedules.
New drug pair helps fight rifampicin-resistant tuberculosis
Scientists paired rifampicin with a probe called AAP-SO2 that binds bacterial RNA polymerase at a different site and slows transcription. The pair killed resistant mutants in culture and was especially effective in a rabbit model.